New Zealand reports first death linked to Pfizer vaccination

New Zealand has reported what it believes to be its first death linked to the Pfizer Covid-19 vaccine.

An independent vaccine safety monitoring board said the woman’s death was “probably” due to myocarditis or inflammation of the heart muscle.
It also noted there were other medical issues which could have “influenced the outcome following vaccination”.
European regulators say myocarditis is a “very rare” side effect and that the vaccine’s benefits outweigh the risks.
However, the Covid-19 Vaccine Independent Safety Monitoring Board said the myocarditis was “probably due to vaccination”.
They said: “This is the first case in New Zealand where a death in the days following vaccination has been linked to the Pfizer COVID-19 vaccine. While the Centre for Adverse Reactions Monitoring has received other reports of deaths in someone recently vaccinated, none are considered related to vaccination.”
The woman’s death is being investigated further and a coroner is due to rule on the case. Officials have not released any further details, including the woman’s age.
The European Medicines Agency has highlighted myocarditis as a “very rare” side effect of the Covid vaccines made by Pfizer and Moderna, adding that the side-effects were more common in younger men.

-->